PJP · Invesco
Invesco Pharmaceuticals ETF
See how 34 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.
Holdings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
Core valuation
Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.28% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.
Largest reported holdings
| Holding | Weight | Trailing P/E | Trailing P/S |
|---|---|---|---|
| PFEPfizer Inc. | 5.21% | 36.99× | 2.52× |
| JNJJohnson & Johnson | 4.95% | 29.63× | 6.37× |
| ABBVAbbVie Inc. | 4.90% | 73.28× | 7.13× |
| AMGNAmgen Inc. | 4.79% | 25.18× | 5.78× |
| LLYEli Lilly and Co. | 4.76% | 40.52× | 13.59× |
| GILDGilead Sciences, Inc. | 4.70% | -56.45× | 6.00× |
| MRKMerck & Co., Inc. | 4.67% | 111.82× | 5.33× |
| ABTAbbott Laboratories | 4.20% | 26.73× | 3.73× |
| TVTXTravere Therapeutics, Inc. | 4.00% | -123.29× | 9.06× |
| CORTCorcept Therapeutics Inc. | 3.74% | 227.37× | 14.84× |
Top 10 of 34 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.
Most similar funds
Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.
- FTXH · First Trust Nasdaq Pharmaceuticals ETF47.79% holdings overlap · Nasdaq
- IHE · iShares U.S. Pharmaceuticals ETF36.78% holdings overlap · NYSE Arca
- IYH · iShares U.S. Healthcare ETF36.01% holdings overlap · US market
- XLV · State Street Health Care Select Sector SPDR ETF35.93% holdings overlap · US market
- VHT · Vanguard Health Care ETF34.77% holdings overlap · US market
Sources and limitations
Holdings are sourced from Invesco and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.
Open official holdings sourceResearch holdings date: 30 April 2026. Informational research, not investment advice.